Brian de la Torre earned his bachelor of science from the University of California, San Diego, where he double-majored in psychology and animal physiology/neuroscience. Before joining the Kaye Laboratory in 2009, de la Torre worked at the University of California, San Diego, and Children's Hospital Los Angeles. He participates in numerous Kaye Laboratory projects, from studies on immune regulation to protein structure/function analysis by mutagenesis, and is an expert in maintaining and screening the myriad of genetically modified mouse strains necessary for the work.
Asha Kadavallorre graduated with her bachelor of science in biological sciences from the University of California, Irvine, in 2006. She joined the Kaye Laboratory in 2010, and has expertise in sophisticated molecular and cellular approaches to study the immune system. Kadavallorre's most recent focus is on dissecting human and murine innate lymphoid cell function. In addition, she participates in the research arm of a clinical trial to characterize natural killer cells used in cancer treatment both phenotypically and molecularly.
Pathricia Angel Leus graduated with a bachelor's degree in biochemistry from Occidental College in 2017. As an undergraduate, she studied quorum sensing on surface bacterial communities of B. bacteriovorus and E. coli. Currently, her research focus in the Kaye Lab is on studying regulatory T cell activity by utilizing a reporter system for human and mouse FOXP3 gene expression.
Bharani Srinivasan, PhD, received his doctorate from the Medical University of Vienna, Austria, in 2014. He studied the role of gliadin proteins in celiac disease. Srinivasan completed his postdoctoral training in allergy immunology and later worked as a research scientist at the pharmaceutical company Shire in Austria. In 2018, he joined the Kaye Lab and is currently working on understanding the functions of human and murine innate lymphoid cells.
Alyson Yeckes earned her bachelor's degree in biology from Colorado College in Colorado Springs. Before joining the Kaye Laboratory, she was a clinical research coordinator and laboratory manager in the laboratory of Edwin de Zoeten, MD, PhD, at the University of Colorado, in Denver, studying the role of regulatory T cells in inflammatory bowel disease. In the Kaye Lab, Yeckes' dissertation research is focused on the mechanisms controlling transcription during T cell development. She is currently utilizing traditional molecular biology and biochemical techniques to determine how the structure of TOX contributes to its function, as well as omics-based approaches such as ATAC-seq and ChIP-seq to identify TOX gene targets.